Acceptability of COVID-19 vaccination among health care workers: a cross-sectional survey in Morocco.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
02 Dec 2021
Historique:
pubmed: 30 10 2021
medline: 3 3 2022
entrez: 29 10 2021
Statut: ppublish

Résumé

This study aimed to evaluate the acceptability of COVID-19 vaccination among health care workers prior to the start of the COVID-19 vaccination campaign in Morocco. This cross-sectional study was conducted in the Cheikh Khalifa University Hospital of Casablanca-Morocco. Utilizing a web-based platform surveys were distributed over a 3-week period via professional mailing list and social media. Odds ratios and 95% confidence intervals were estimated by using logistic regression models. A total of 303 health care workers participated in this study. The results showed a relatively high rate of vaccination acceptability (62.0%) among health care workers included in this study. Participants were more likely to accept the COVID-19 vaccine if they were physician, nurse, or technician (OR 1.79; 95% CI: 1.09-2.95), had high score of confidence in the information circulating about COVID-19 (OR 1.91; 95% CI: 1.36-2.69), or had high score of perceived severity of COVID-19 (OR 1.55; 95% CI: 1.11-2.15). Reasons of hesitation/or refusal of COVID-19 vaccine were fear of the likely side effects of the vaccine for 74.8% of participants, and concern about the effectiveness of the vaccine for 47.8%. This study showed a relatively high rate of the COVID-19 vaccination acceptance among health care workers in Morocco. Willingness to be vaccinated was significantly associated with job category, confidence in the information circulating about COVID-19, and perceived severity of COVID-19. These results could be useful in the development of educational interventions to increase the acceptance of COVID-19 vaccine among health care workers in Morocco and similar settings.

Identifiants

pubmed: 34715004
doi: 10.1080/21645515.2021.1989921
pmc: PMC8903996
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5076-5081

Références

Health Commun. 2018 Sep;33(9):1131-1140
pubmed: 28622038
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
Int J Nurs Stud. 2021 Feb;114:103854
pubmed: 33326864
Vaccine. 2015 Aug 14;33(34):4180-90
pubmed: 25896377
Vaccines (Basel). 2021 Jan 18;9(1):
pubmed: 33477725
Nat Rev Drug Discov. 2020 May;19(5):305-306
pubmed: 32273591
Immunology. 2020 Jul;160(3):223-232
pubmed: 32460358
Front Med (Lausanne). 2021 Mar 01;8:644300
pubmed: 33732723
Br J Health Psychol. 2010 Nov;15(Pt 4):797-824
pubmed: 20109274
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
Acad Emerg Med. 2021 Apr;28(4):455-458
pubmed: 33608937
Vaccines (Basel). 2021 Feb 28;9(3):
pubmed: 33670913
Med Lav. 2020 Nov 17;111(6):445-448
pubmed: 33311419
J Med Internet Res. 2020 Sep 8;22(9):e19913
pubmed: 32841153
Vaccine. 2010 Mar 19;28(14):2679-86
pubmed: 20064475
J Public Health (Oxf). 2021 Dec 10;43(4):695-702
pubmed: 33693905
EBioMedicine. 2015 Jun 23;2(8):891-7
pubmed: 26425696
Risk Manag Healthc Policy. 2021 Apr 08;14:1413-1429
pubmed: 33854390
Clin Infect Dis. 2020 Jul 28;71(15):703-705
pubmed: 32282038
Euro Surveill. 2021 Jan;26(3):
pubmed: 33478623
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
PLoS One. 2021 Nov 29;16(11):e0244415
pubmed: 34843462
J Hosp Infect. 2021 Feb;108:168-173
pubmed: 33259883
Infect Drug Resist. 2021 May 13;14:1773-1780
pubmed: 34012276
Int J Environ Res Public Health. 2021 Mar 08;18(5):
pubmed: 33800187

Auteurs

Mohamed Khalis (M)

International School of Public Health, Mohammed VI University of Health Sciences, Casablanca, Morocco.

Asmaa Hatim (A)

Faculty of Dentistry, Mohammed VI University of Health Sciences, Casablanca, Morocco.

Latifa Elmouden (L)

Faculty of Dentistry, Mohammed VI University of Health Sciences, Casablanca, Morocco.

Mory Diakite (M)

International School of Public Health, Mohammed VI University of Health Sciences, Casablanca, Morocco.

Abdelghafour Marfak (A)

National School of Public Health of Rabat, Ministry of Health, Hanoi, Morocco.
Laboratory of Health Sciences and Technology, Higher Institute of Health Sciences, Hassan 1st University of Settat, Settat, Morocco.

Soukaina Ait El Haj (S)

International School of Public Health, Mohammed VI University of Health Sciences, Casablanca, Morocco.

Rachid Farah (R)

Cheikh Khalifa Ibn Zaid University Hospital of Casablanca, Casablanca, Morocco.

Mohamed Jidar (M)

Cheikh Khalifa Ibn Zaid University Hospital of Casablanca, Casablanca, Morocco.

Kaba Kanko Conde (KK)

International School of Public Health, Mohammed VI University of Health Sciences, Casablanca, Morocco.

Kenza Hassouni (K)

International School of Public Health, Mohammed VI University of Health Sciences, Casablanca, Morocco.

Hafida Charaka (H)

Department of Research and Development, Hassan II University Hospital, Fez, Morocco.

Mark Lacy (M)

School of Medicine, University of New Mexico, Albuquerque, NM, USA.

Fatima-Zahra Aazi (FZ)

Faculty of Legal, Economic and Social Sciences Ain Chock, Hassan II University of Casablanca, Casablanca, Morocco.

Chakib Nejjari (C)

International School of Public Health, Mohammed VI University of Health Sciences, Casablanca, Morocco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH